Canopy Growth (CGC) Invested Capital (2017 - 2026)
Canopy Growth (CGC) posted Invested Capital of $11.8 million for Q1 2026, up 782.21% sequentially from $1.3 million in Q3 2025, and up 299.0% YoY from $3.0 million in Q1 2025.
Canopy Growth (CGC) Invested Capital (2017 - 2026) Analysis & Trends
Canopy Growth has reported Invested Capital for 10 years, with the latest figure at $11.8 million in Q1 2026.
- Quarterly Invested Capital rose 299.0% year-over-year to $11.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.7 million (down 83.6% YoY) and the FY2026 annual result came in at $11.8 million, up 299.0% from the prior year.
- Invested Capital grew to $11.8 million in Q1 2026 per CGC's latest filing, from $1.3 million in the prior quarter.
- Over five years, Invested Capital peaked at $411.9 million in Q1 2023 and troughed at $1.3 million in Q3 2025.
- A 5-year average of $103.0 million and a median of $52.2 million in 2023 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2023 and 2024: Invested Capital soared 5512.91% in 2023, then sank 99.05% in 2024.
- Over 5 years, Invested Capital stood at $335.6 million in 2022, then plunged by 80.01% to $67.1 million in 2023, then tumbled by 96.62% to $2.3 million in 2024, then slumped by 40.8% to $1.3 million in 2025, then jumped by 782.21% to $11.8 million in 2026.
- According to Business Quant data, Invested Capital over the past three periods registered $11.8 million, $1.3 million, and $4.6 million for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 630.00 Mn |
| 10 | Canopy Growth | 443.38 Mn | 196.37 Mn | 16.08 Mn | 20.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.84 Mn |
| Mar 31, 2026 | 11.84 Mn |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | 4.55 Mn |
| Mar 31, 2025 | 2.97 Mn |
| Dec 31, 2024 | 2.27 Mn |
| Sep 30, 2024 | 101.10 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Mar 31, 2024 | 77.13 Mn |
| Dec 31, 2023 | 67.09 Mn |
| Sep 30, 2023 | 37.27 Mn |
| Jun 30, 2023 | 188.27 Mn |
| Mar 31, 2023 | 411.93 Mn |
| Dec 31, 2022 | 335.56 Mn |
| Sep 30, 2022 | 246.87 Mn |
| Jun 30, 2022 | 151.43 Mn |
| Mar 31, 2022 | 7.34 Mn |
| Dec 31, 2021 | 12.46 Mn |
| Sep 30, 2021 | 7.01 Mn |
| Jun 30, 2021 | 12.78 Mn |